Upload
others
View
2
Download
0
Embed Size (px)
Citation preview
t *1, . f .
- ' . . " . : .
***-");" r":t :*1| 1 ; , , . .
, ' . :
I
t
PROCEEDING BOOK
BALI ENDOCRINE UPDATE
(BEU Xl l l )
"EndocrinologY and BeYond"
EDITOR
Prof. Dr. dr. Ketut Suastika, SpPD-KEMD, FINASIM
Prof. Dr. dr. AA. Gd. Budiar:tha, Sp.PD-KEMD, FINASIM
Dr. dr. Wira Gotera, Sp'PD-KEMD, FlNAS|M
Dr. dr. Made Ratna Saraswati, Sp.PD-KEMD, FINASIM
dr. I Made Pande Dwipayana, Sp.PD-KEMD, FINASIM
Aula Nusantara Gedung Agrokompleks
Universitas UdaYana
16-17 APril2016
KATALOG DALAM TERBITAN
BAU ENDOCR|NOTOGT UPDATE (BEU Xilt)
Endocrinology and Beyond
Denpasar, PT. Percetakan Bali
xiv + 138 hlm; 16,5 x24 cm
f SBN : 97 8-602-L672-48-8
BAL| ENDOCRTNOLOGT UPDATE (BEU XiltlEndocrinology and Beyond
EDITOR
Prof. Dr. dr. Ketut Suastika, SpPD-KEMD, FINASIMProf. Dr. dr. AA. Gd. Budiartha, Sp.PD-KEMD, FtNASIMDr. dr. Wira Gotera, Sp.PD-KEMD, FINASIMDr. dr. Made Ratna Saraswati, Sp.PD-KEMD, FINASIMdr. I Made Pande Dwipayana, Sp.pD-KEMD, FtNASIM
Penerbit:
PT. Percetakan Bali, Jl. Gajah Mada l/1 Denpasar gOLlZ,
Telp. (0361) 234723, 23521L
Bali Endocrine Update (BEU) Xlll 2016
DAFTAR ISI
KATA PENGANTAR
DAFTAR ISI
JADWATACARA
SUSUNAN PANITIA
MATERI
DIABETES TREATMENT: PAST, PRESENT, FUTURE
Anak Agung Gde Budiartha
NEW CI-ASSES OF ANTIHYPERGLICEMIC AGENT
I Made Pande Dwipayana
PENGHAMBAT SODIUM GLUCOSE CO-TRANSPORTER 2
(SGLT2 TNHTBTTOR):
OBAT ANTI HIPERGIIKEMIK ORAI YANG TIDAK BERGANTUNG
tNsuuNMade Ratna Saraswati
BENEFIT OF ONCE DAIIY IEVEMIR foT TYPE 2 DM MANAGEMENT
Anak Agung Gde Budiartha
A NEWTHERAPY: ROIE OF GLP-1IN TYPE 2 DM MANAGEMENT
Wira Gotera
KEUNTUNGAN TERAPI BERBASIS INKRETIN PADA DIABETES MELTITUS
TIPE 2: BUKTI DARI BEBERAPA UJI KtlNtS
I Made Pande Dwipayana
xill
L2
19
20
22
Bali Endocrine Update {BEU} Xlll2015
TRIAT EVALUATING CARDIOVASCU IAR OUTCOM ES WITH
SITAGUffiN (TECOS): CARDIOVASCULAR SAFETY TRIAI .........
Made Ratna Saraswati
HIDDEN FACES OF DIABETES : UNMASKING DIABETIC DYSI'IPEDEMIA &
NEWEST LIPID GUIDETINE ON DM ...............
Anak Agung Gde Budiartha
STATIN THERAPHY IN DIABETES AND CKD : FRIEND OR FOE ?
Wira Gotera
DIAGNOSIS AND TREATMENT OF HYPOGONADISM IN MAIE
A. A. Gede Budhitresna
HIPOGONAD PADA REMAJA .................
I Made Arimbawa
Surgical Endocrinology
Nyoman P. Riasa
PENATALAKSANAAN KAKI DIABETES
I Made Pande Dwipayana
THE ROLE OF HYATURONIC ACID PIUS SITVER SUTFADIAZINE IN
THE TREATMENT OF DIABETIC WOUND ............. ............,........ ir........
lNyoman Semadi
sHoutD sutFoNytuREA (su) REMATN AN ACCEPTABIE l't UNE ADD ON
TO METFORMIN THERAPY IN T2DM ? ON FOCUS ON GTIMEPIRTDE
PLUS METFORMTN ..........
SriMurtiwi
INISIASI DAN TITRASI INSUTIN BASAT PADA DIABETES MELTITUS TIPE 2:
FOKUS INSULIN GIARGtNE
Ketut Suastika
DIAGNOSIS DAN TERAPI MEDIK NODULTIROID
Ketut Suastika
vi
37
42
43
52
55
56
61
63
77
82
-.-
Bali Endocrine Update (BEU) Xlll 2015
SET YOURSETF FREE FROM THYROID DISORDERS .................
Risa Anwar
WORKSHOP: MONITORING GTUKOSA DARAH MANDIRI
Made Ratna Saraswati
SINDROM CUSHING
Ketut Suastika
MANAGEMENT PRE & POST HYPOPHYSECTOMY IN PITUITARYADENOMA .."
Wira Gotera
LAMPI RAN P R ESE NTASI P OSTER
ANAIISIS MASATAH TERKAIT OBAT/DRUG RETATED PROBLEMS (DRPs) pada
PASIEN DIABETES MELTITUS TIPE II NON KOMPTIKASI
Made Ary Sarasmita, Ni Wayan lka Himawari
IDENTIFI KASI MASATAH TERKAIT OBAT/DRUG RELATED PROBLEMS ( DRPS)
PADA PASIEN DIABETES METTITUSTIPE II DENGAN DW..............
Made Ary Sarasmita, Ni Wayan lka Himawari, NKND Jayanthi,
DMA Kencanasari
EVIDENCE BASED MEDICINE PENGGUNAAN ANTIPTATELET SEBAGAI
RHEOLOGIC VASCULAR AGENT PADA PASIEN DIABETES MEILITUS
DENGAN GANGGUAN VASCUTAR
Made Ary Sarasmita
HUBUNGAN STATUS SOSIAT EKONOMI KELUARGA DENGAN KEGEMUKAN
PADA REMAJA SMA DI DENPASAR
Anak Agung Gede Ari Nanda Bhaswara
HUBUNGAN OBESTTAS PADA ORANG TUA DENGAN TERJADINYA OBESITAS
PADA ANAK REMAJA SMA DI KOTA DENPASAR PROVINSI BALI
Theodorus Onesiforus Gozali
83
87
94
109
Bali Endocrine Update {BEU) Xlll 2016
HUBUNGAN SINDROM METABOLIK DENGAN KEJADIAN DISFUNGSI EREKSI
PADA PASIEN DIABETES MELTITUS TIPE 2 DI POLIKTINIK PENYAKIT
DALAM RSUP SANGTAH DENPASAR
Ni Putu Tesi Maratni
ASOS|AS| ANTARA PARAMETER ANTROPOMETR|, KADAR SERUM
TRtGtfsERf DA {TG}, DAN GAMMA GLUTAMYL TRANSFERASE (GGT}
DENGAN STEATOSIS HEPAR PADA PEREMPUAN MUDA DENGAN
OBESITAS DI PROVINSI BALI
Tjokorda lstri Pramitasuri, Arya Krisna Manggala
OBESITAS TIDAK TERBUKTI MEMPENGARUHI PENURUNAN TEKANAN
DARAH PADA KETOMPOK PASIEN DENGAN HIPERTENSIDI RUMAH SAKIT
DR. HAUTUSY AMBON TAHUN 2014
Leonard Kencana
GLYCATED ALBUMIN SEBAGAI PENANDA KONTROT GTIKEMIK PADA
PENDERITA DIABETES METITUS TIPE 2
Anselmus Ake, Made Ratna Saraswati, I Gde Raka Widiana
HUBUNGAN ANTARA POLA MAKANAN DENGAN OBESITAS REMAJAPADA S|SWA-SISW| SEKOTAH MENENGAH ATAS (SMA) Dt DENPASAR
Nyoman Arya Shridewi Abhigamika, Made Ratna Saraswati
THE CHARCOAT OSTEOARTHROPATHY (COA) tN 64 YEARS OtD FEMATE
PATIENT WITH DIABETES METIITUS WPE 2
I Gede Agus Aprianta
Atrial Fibrilasi pada Penyakit lantung Tiroid
Ayuningtyas.A.S, D.C.Wulandari, K.Suryana
GRAVES' DISEASE AS A LATE MANIFESTATION OF IMMUNE
RECONSTITUTION INFAMMATORY SYNDROME AFTER HIGHTY ACTIVE
ANTIRETROVIRAL THERAPY IN HIV INFECTED PATIENT
Putu Ayu Sri Saraswati
vill
Bali Endocine Update (BEU) Xffi 2016
SEORANG PENDERITA KRISIS TIROID AI(IBAT STRUMA MUTTINODULAR
TOKSIK YANG DIPICU INFEKSI VIRUS DENGUE
lda Bagus Aditya Nugraha
PROGRAM KEGIATAN CLUB DIAMED,,
HIDUP NYAMAN BERSAMA DIABETES"
I Ketut Pasek, Team PKRS RS BaliMed
PROGRAM KEGIATAN ROYAT DTABETES CIINIC
Doddy, Bali Royal Hospital
EDUKASI MEDIS DAN KONSUTTASI GIZI DI KTINIK SAHABATSEBAGAI
BENTUK KEPEDUTIAN DIABETES
Putu Arya Nugraha, RS Kertha Usada Slngaraja
MENINGKATKAN PERAN AKTIF "CAREGIVER" DALAM PENATATAKSANAAN
DIABETES METITUS
Dewi Catur Wulandari, RSUD Wangaya
PERANAN TOMBA SETFIE MELALUI FACEBOOK SEBAGAI MEDIA EDUKASI
KESEHATAN DATAM UPAYA MENINGKATKAN PUBTIC AWARENESS
TENTANG DIABETES METLITUS DI KABUPATEN SIKA,
PROVINSI NUSA TENGGARA TIMUR
lvan Banjuradja, Asep Purnama, RSUD T.C. Hil lers
KOLABORASI 3P diPUSKESMAS BULETENG II SEBAGAI IMPTEMENTASI
COLLABORATIVE CARE DATAM TATATAKSANA DIABETES METITUS
IGA Raka Mahasadu, Puskesmas Buleleng ll Slngaraja
t29
130
L32
133
134
136
137
IX
Bali Endogine Update (BEU) Xlll2016
THE ROIE OF HYALURONIC ACID PLUS SILVER SULFADIAZINE IN THE
TREATMENT OF DIABETIC WOUND
I Nyoman Semadi
Cardiothoracic and Vascular Division, Department of Surgery,
Faculty of Medicine Udayana University/ Sanglah General Hospital Denpasar
Absffact
fn united states, there are about 23.6 million children and adults or 7'8% of the
population who suffer from diabetes. ln canada an estimated 25% Canadians with
diabetes who develop foot complications and 1 in 15 end up having a limb amputation
during their lifetime. Diabetic foot ulcer (DFUs) is a major complication of diabetes
melfitus and the prevalence of DFUs: !2%to 15%. DFUs patients need lower extremity
amputation (LEA) is t2%. Conva-lateral amputation after 3-5 years is 50 %' Three
years mortality rate is 20-50%. Major increase of morbidity and mortality due to
failure of the wound healing process. A key feature of wound healing is stepwise repair
of lost extracellular matrix {ECM) that forms the largest component of the dermal skin
layer. Non-heqling chronic diabetic ulcers are often treated with extracellular matrix
replacement therapy. lt is a common trend to use such advanced moist wound
therapy, bio-engineered tissue or skin substitute, growth factors, and other' Moist
wound therapy is known to promote fibroblast and keratinocyte proliferation and
migration, collagen synthesis, early angiogenesis and wound contraction. The porpuse
of wound care in manage of diabetic wound is to give optimum protection of
environment wound healing (Hailey, 2007; Pinzur, 2009). Wound was covered,
dressing and bandaging properly to keep optimum environment and prevent bacteria
contamination (Espensen, 2O07; Pinzur, 2009). Moist environment of the wound can
elevate reepitelial and wound healing prosess in a whole body (Barros et al, 2007)'
Hyaloronic acid (HA) is an extracellular matrix component of connective tissue to
have role of wound healing by moist of an environment to grow the tissue and
reepitelisation. Hyaluronic acid has been use long time ago for opthalmology,
connective tissue disease, joint inflamation and rhematoid' Topical aplicatian of HA
give the good result in chronic wound of the diabetic patient (Barrois, 2007; Ballard ,
2009). Coupling the considerations regarding HA activity on the tissue repair in
:=
==a
Bali Endocrine Update (BEU) Xlll2016
diabetic with those supporting SSD application in various types of wounds to control
microbial proliferation, it appaers that simultaneous application of SSD and HA rnay be
rational choice for thetreatment of chronic lesion affecting diabetic'patients. The
available evidence fully support the rationale for clinical use of the formulation here
described in diabetic patient, on the basis of the preclinical data available for each
component in microorganisms, in experimental animal and in human cells.
Key word: hyaluronic acid and silrier sulfadiazine, topical application, wound care
62
: :